Nimbus Therapeutics Announces Closing of Takeda's Acquisitio

Nimbus Therapeutics Announces Closing of Takeda's Acquisition of TYK2 Subsidiary

BOSTON--(BUSINESS WIRE)--Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a clinical-stage company that designs and develops breakthrough m

Related Keywords

Boston , Massachusetts , United States , Jeb Keiper , Nimbus Lakshmi Inc , Nimbus Therapeutics , Nimbus Lakshmi , Chief Executive Officer , Psoriasis Area , Severity Index ,

© 2025 Vimarsana